期刊文献+

护心康片对动脉粥样硬化兔sCD40L和IL-1β的影响

Effect of Huxinkang on Atherosclerosis s CD40L and IL-1 Beta in Rabbits
下载PDF
导出
摘要 目的:研究护心康对动脉粥样硬化(AS)兔血清s CD40L、白细胞介素-1β(IL-1β)的影响。方法:建立AS兔模型,将动物随机分为4组,即正常对照组、模型组、护心康组和辛伐他汀组,除正常组以普通饲料喂养外,其它组均以高脂饲料喂养。在12周造模成功后护心康组给予护心康1.08 g/(kg·d)混悬液灌胃,辛伐他汀组给予辛伐他汀2.5 mg/(kg·d)混悬液灌胃,干预4周,正常对照组、模型组以等量生理盐水灌胃。16周后,检测血清s CD40L(soluble CD40L)、IL-1β的含量。结果:酶联免疫吸附法实验(ELISA)检测结果显示:护心康组可显著降低血清s CD40L、IL-1β的水平(P<0.01)。结论:护心康能降低血清s CD40L、IL-1β中的含量,可能是其抗AS的机制之一。 Objective: To study the effects of Huxinkang(护心康片) on sCD40L and interleukin -1 beta(IL-113) in aorta of atherosclerotic(AS) rabbits. Me/hods: The experimental model of AS was established by some rabbits. Rabbits were divided into 4 groups, whictl included blank control group, model group, Huxinkang group and simvastatin group. In addition to the normal group with normal diet, the other groups were fed by high fat diet. Established rabbit model of atherosclerosis successfully at the end of 12th week. ttuxinkang [l.08g/(kg'd)] was administered through intra gastric pathway in Huxinkang group and Simvas- tatin [2.5 mg/(kg·d)] was administered through intra gastric pathway in Simvastatin group for four weeks. Meanwhile the same volume of normal saline(NS) was administered in normal group and model group. After 16 weeks, content of sCD40L and IL-1β were detected by ELISA methods. Results: The results of ELISA showed Huxinkang group can significantly decrease the senml sCD4OL, IL-1βlevcls (P〈0.01). Conclusions: tluxinkang has a significant inhibitory effect on proinflammatory cytokine sCD40L and IL-1β,whieh may be partially responsible for its anti AS effects.
机构地区 湖南中医药大学
出处 《中医药导报》 2015年第7期6-8,共3页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金 湖南省教育厅科学研究项目(09B074) 湖南省中药粉体与创新药物研究省部共建国家重点实验室培育基地开放基金项目(ZYFT201304)
关键词 SCD40L 护心康 动脉粥样硬化 sCD40L rabbits Huxinkang atherosclerosis
  • 相关文献

参考文献9

二级参考文献33

  • 1顾晴,陈纪林,阮英茆.阿司匹林、氯吡格雷及合用对兔动脉粥样硬化病变进展的抑制作用[J].中国医学科学院学报,2005,27(1):87-91. 被引量:46
  • 2张峻,陈纪林,顾晴,关婷,陈曦.抗血小板药物抑制动脉粥样硬化进展及机制研究[J].中国循环杂志,2005,20(6):463-467. 被引量:25
  • 3Hansson GK. Inflammation, atherosclerosis and coronary artery disease. N Engl J Med,2005,352:1685-1695.
  • 4Cyrus T, Sung S, Zhao L, et al. Effect of low-dose aspirin on vascular inflammation, plaque stability, and atherogenesis in low-density lipoprotein receptor-deficient mice. Circulation, 2002, 106 : 1282- 1287.
  • 5Cavendish JJ, Fugit RV, Safani M, et al. Role of antiplatelet therapy in cardiovascular disease I : Acute coronary syndromes. Curr Med Res Opin ,2004,20:1839-1838.
  • 6Andre P, Nannizzi-Alaimo L, Prasad SK, et al. Platelet-derived CD4OL: the switch-hitting player of cardiovascular disease. Circulation, 2002,106 : 896-899.
  • 7金冬雁,黎孟枫译.分子克隆试验指南.第2版.北京:科学出版社,1998.602-691.
  • 8Lu L, Li W, Fu F, et al. Blockade of the CD40-CD4OL pathway potentiates the capacity of donor-drived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplanatation, 1997,64: 1808-1815.
  • 9Grainger DJ, Reckless J, McKilligin E,et al. Apolipoprotein E modulates clearance of apoptotic bodies in vitro and in vivo, resulting in a systemic proinflammatory state in apolipoprotein E-deficient mice. J Immunol,2004,366-375.
  • 10Cuaz-Perolin C, Jguirim I, Larigauderie G, et al. Apolipoprotein E knockout mice over-expressing human tissue inhibitor of metalloproteinase 1 are protected against aneurysm formation but not against atherosclerotic plaque development. J Vasc Res, 2006,43:493-501.

共引文献1359

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部